Top Markets
#1 The Bitcoin Bull The Bitcoin Bull +19.17%
#2 PondCoin PondCoin +12.87%
#3 Gas Gas +12.71%
#4 Siacoin Siacoin +12.33%
#5 Creditcoin Creditcoin +9.06%
#6 Unit Zcash Unit Zcash +8.22%
#7 OmniBridge Bridged Zcash (Solana) OmniBridge Bridged Zcash (Solana) +8.22%
#8 NEAR Intents Bridged ZEC NEAR Intents Bridged ZEC +8.22%
#9 Zcash Zcash +8.22%
#10 Binance-Peg ZEC Binance-Peg ZEC +8.03%
Coin of the day
The Bitcoin Bull The Bitcoin Bull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
G&E Herbal Biotechnology Co., Ltd. G&E Herbal Biotechnology Co., Ltd.

G&E Herbal Biotechnology Co., Ltd.

4911
Rang in Aktien #24234
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise,... G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
Aktienkurs
$0.91899191
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$63.24M
Veränderung (1 Tag)
0.17%
Veränderung (1 Jahr)
-39.70%
Land
CN
Handel G&E Herbal Biotechnology Co., Ltd. (4911)

Kategorie

Healthcare
Gewinn für G&E Herbal Biotechnology Co., Ltd. (4911)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von G&E Herbal Biotechnology Co., Ltd. betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von G&E Herbal Biotechnology Co., Ltd. von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH